Alembic Pharma Jumps On U.S. FDA Nod For Fesoterodine Fumarate Tablets

Shares of Alembic Pharmaceuticals Ltd. rose 1.5% to Rs 773.5 apiece after the company received the U.S. FDA nod for its ANDA for Fesoterodine Fumarate Extended-Release tablets, 4 mg and 8 mg. It is indicated for treatment of overactive bladder in adults. The estimated market size of $225 million for twelve months ending September 2021, according to IQVIA.

Read More →

Sensex, Nifty Open Higher Ahead Of Budget 2022

India’s stock benchmarks opened higher, ahead of federal budget due to be presented in the parliament by Finance Minister Nirmala Sitharaman at 11 a.m., aided by information technology, banking, metal and realty stocks. The rise comes amid rebound in global equities due to positive spillover effects from the technology-led rally in the U.S.

Read More →

Adani Wilmar IPO Subscription Status: Day 3 Live Updates

Adani Wilmar IPO Subscription: Retail and non-institutional investors continue to pile into the initial public offering of Adani Wilmar Ltd., a consumer goods joint venture between Adani Group and Wilmar Group, on the third day.

The IPO was subscribed 1.13 times on the second day and 57% on day one.

Read More →

UPL Q3 Net Income Above Estimate

UPL Q3 Net Income Above Estimate

Shares of UPL Ltd. rose nearly 3% in intraday trade to Rs 812.7 apiece. The company reported net income for the third quarter that beat the average analyst estimate.

Read More →